172 related articles for article (PubMed ID: 37506144)
1. MiR-223-3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3.
Zheng R; Xie J; Li W; Shang J; Shi Z; Zhu S; Gui L; Huang L; Shu L; Liu D; Gong Y; Li X; Chai W; Huang X; Wu X; Yue J
Immun Inflamm Dis; 2023 Jul; 11(7):e939. PubMed ID: 37506144
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.
Liu C; Yang D; Wang H; Hu S; Xie X; Zhang L; Jia H; Qi Q
Mol Cell Biochem; 2021 Dec; 476(12):4245-4263. PubMed ID: 34351574
[TBL] [Abstract][Full Text] [Related]
3. Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease.
Inoue T; Murakami S; Matsumoto K; Matsuda A
Pediatr Rheumatol Online J; 2020 Oct; 18(1):76. PubMed ID: 33023630
[TBL] [Abstract][Full Text] [Related]
4. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.
Jia S; Li C; Wang G; Yang J; Zu Y
Clin Exp Immunol; 2010 Oct; 162(1):131-7. PubMed ID: 20718783
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.
Ni FF; Li CR; Li Q; Xia Y; Wang GB; Yang J
Clin Exp Immunol; 2014 Nov; 178(2):384-93. PubMed ID: 25039241
[TBL] [Abstract][Full Text] [Related]
6. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[TBL] [Abstract][Full Text] [Related]
7. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells.
Luo Y; Yang J; Zhang C; Jin Y; Pan H; Liu L; Gong Y; Xia Y; Wang G; Zhang J; Li C; Li Q
J Leukoc Biol; 2020 Jan; 107(1):133-144. PubMed ID: 31583766
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
10. MiR-223-3p Alleviates Vascular Endothelial Injury by Targeting IL6ST in Kawasaki Disease.
Wang X; Ding YY; Chen Y; Xu QQ; Qian GH; Qian WG; Cao L; Zhou WP; Hou M; Lv HT
Front Pediatr; 2019; 7():288. PubMed ID: 31396494
[No Abstract] [Full Text] [Related]
11. [Recombinant human interleukin 35 (rhIL-35) alleviates the damage of coronary artery endothelial cells in Kawasaki disease by inhibiting NF-κB pathway].
Tian Z; Zhou Z; Yang Y; Li J; Hu L; Jiao R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Oct; 38(10):880-885. PubMed ID: 36163618
[TBL] [Abstract][Full Text] [Related]
12. MiR-197-3p regulates endothelial cell proliferation and migration by targeting IGF1R and BCL2 in Kawasaki disease.
Li Y; Wu X; Gao F; Wang X
Int J Clin Exp Pathol; 2019; 12(11):4181-4192. PubMed ID: 31933818
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
14. Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy.
Olivito B; Taddio A; Simonini G; Massai C; Ciullini S; Gambineri E; de Martino M; Azzari C; Cimaz R
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):93-7. PubMed ID: 20412712
[TBL] [Abstract][Full Text] [Related]
15. Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress.
Xu M; Qi Q; Men L; Wang S; Li M; Xiao M; Chen X; Wang S; Wang G; Jia H; Liu C
Vascul Pharmacol; 2020 Apr; 127():106660. PubMed ID: 32070767
[TBL] [Abstract][Full Text] [Related]
16. MiR-23a-3p-regulated abnormal acetylation of FOXP3 induces regulatory T cell function defect in Graves' disease.
Zhang D; Qiu X; Li J; Zheng S; Li L; Zhao H
Biol Chem; 2019 Apr; 400(5):639-650. PubMed ID: 30391932
[TBL] [Abstract][Full Text] [Related]
17. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura].
Wang Q; Shi YY; Cao M; Dong W; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow-Derived MicroRNA-223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease.
Chu M; Wu R; Qin S; Hua W; Shan Z; Rong X; Zeng J; Hong L; Sun Y; Liu Y; Li W; Wang S; Zhang C
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28196816
[TBL] [Abstract][Full Text] [Related]
19. miR-27b Suppresses Endothelial Cell Proliferation and Migration by Targeting Smad7 in Kawasaki Disease.
Rong X; Ge D; Shen D; Chen X; Wang X; Zhang L; Jia C; Zeng J; He Y; Qiu H; Su X; Chu M
Cell Physiol Biochem; 2018; 48(4):1804-1814. PubMed ID: 30078021
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-Derived Semaphorin 4D Induces Inflammatory Cytokine Production of Endothelial Cells via Different Plexin Receptors in Kawasaki Disease.
Huang J; Wu S; Cao S; Zhu X; Zhang S
Biomed Res Int; 2020; 2020():6663291. PubMed ID: 33381571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
